6.
Zvereva M, Roberti G, Durand G, Voegele C, Nguyen M, Delhomme T
. Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA. EBioMedicine. 2020; 55:102462.
PMC: 7251242.
DOI: 10.1016/j.ebiom.2019.09.042.
View
7.
Chan K, Jiang P, Zheng Y, Liao G, Sun H, Wong J
. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem. 2012; 59(1):211-24.
DOI: 10.1373/clinchem.2012.196014.
View
8.
Tompkins J
. Discovering DNA Methylation, the History and Future of the Writing on DNA. J Hist Biol. 2022; 55(4):865-887.
PMC: 9941238.
DOI: 10.1007/s10739-022-09691-8.
View
9.
Stejskal P, Goodarzi H, Srovnal J, Hajduch M, J van t Veer L, Magbanua M
. Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance. Mol Cancer. 2023; 22(1):15.
PMC: 9862574.
DOI: 10.1186/s12943-022-01710-w.
View
10.
Moreno-Manuel A, Calabuig-Farinas S, Obrador-Hevia A, Blasco A, Fernandez-Diaz A, Sirera R
. dPCR application in liquid biopsies: divide and conquer. Expert Rev Mol Diagn. 2020; 21(1):3-15.
DOI: 10.1080/14737159.2021.1860759.
View
11.
Nikanjam M, Kato S, Kurzrock R
. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022; 15(1):131.
PMC: 9465933.
DOI: 10.1186/s13045-022-01351-y.
View
12.
Kaneko A, Kanemaru H, Kajihara I, Mijiddorj T, Miyauchi H, Kuriyama H
. Liquid biopsy-based analysis by ddPCR and CAPP-Seq in melanoma patients. J Dermatol Sci. 2021; 102(3):158-166.
DOI: 10.1016/j.jdermsci.2021.04.006.
View
13.
Ma X, Shao Y, Tian L, Flasch D, Mulder H, Edmonson M
. Analysis of error profiles in deep next-generation sequencing data. Genome Biol. 2019; 20(1):50.
PMC: 6417284.
DOI: 10.1186/s13059-019-1659-6.
View
14.
Peng R, Zhang R, Horan M, Zhou L, Chai S, Pillay N
. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis. Oncologist. 2020; 25(3):218-228.
PMC: 7066684.
DOI: 10.1634/theoncologist.2019-0239.
View
15.
Deveson I, Gong B, Lai K, LoCoco J, Richmond T, Schageman J
. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nat Biotechnol. 2021; 39(9):1115-1128.
PMC: 8434938.
DOI: 10.1038/s41587-021-00857-z.
View
16.
Gargis A, Kalman L, Lubin I
. Assuring the Quality of Next-Generation Sequencing in Clinical Microbiology and Public Health Laboratories. J Clin Microbiol. 2016; 54(12):2857-2865.
PMC: 5121372.
DOI: 10.1128/JCM.00949-16.
View
17.
Maschietto C, Otto G, Rouze P, Debortoli N, Bihin B, Nyinkeu L
. Minimal requirements for ISO15189 validation and accreditation of three next generation sequencing procedures for SARS-CoV-2 surveillance in clinical setting. Sci Rep. 2023; 13(1):6934.
PMC: 10140720.
DOI: 10.1038/s41598-023-34088-w.
View
18.
Zhang R, Peng R, Li Z, Gao P, Jia S, Yang X
. Synthetic Circulating Cell-free DNA as Quality Control Materials for Somatic Mutation Detection in Liquid Biopsy for Cancer. Clin Chem. 2017; 63(9):1465-1475.
DOI: 10.1373/clinchem.2017.272559.
View
19.
Zhang Y, Bae Y, Shibayama S, Wang X, Kato M, Dong L
. International co-validation on absolute quantification of single nucleotide variants of KRAS by digital PCR. Anal Bioanal Chem. 2022; 414(19):5899-5906.
DOI: 10.1007/s00216-022-04155-8.
View
20.
Dong L, Wang S, Fu B, Wang J
. Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection. Sci Rep. 2018; 8(1):9650.
PMC: 6269532.
DOI: 10.1038/s41598-018-27368-3.
View